Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding.

Allègre J, Cartier J, Glorian V, Droin N, Dumetier B, Kayaci C, Berthelet J, Gemble S, Vuillier C, Maillet L, Garrido C, Dubrez L.

PLoS One. 2018 Oct 25;13(10):e0206253. doi: 10.1371/journal.pone.0206253. eCollection 2018.

2.

Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up.

Philip CA, Le Mitouard M, Maillet L, de Saint-Hilaire P, Huissoud C, Cortet M, Dubernard G.

Eur J Obstet Gynecol Reprod Biol. 2018 Aug;227:46-51. doi: 10.1016/j.ejogrb.2018.04.001. Epub 2018 Apr 7.

PMID:
29886317
3.

The challenges of implementing advanced access for residents in family medicine in Quebec. Do promising strategies exist?

Abou Malham S, Touati N, Maillet L, Breton M.

Med Educ Online. 2018 Dec;23(1):1438719. doi: 10.1080/10872981.2018.1438719.

4.

E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

Vuillier C, Lohard S, Fétiveau A, Allègre J, Kayaci C, King LE, Braun F, Barillé-Nion S, Gautier F, Dubrez L, Gilmore AP, Juin PP, Maillet L.

EMBO Rep. 2018 Feb;19(2):234-243. doi: 10.15252/embr.201744046. Epub 2017 Dec 12.

PMID:
29233828
5.

What Are the Factors Influencing Implementation of Advanced Access in Family Medicine Units? A Cross-Case Comparison of Four Early Adopters in Quebec.

Abou Malham S, Touati N, Maillet L, Gaboury I, Loignon C, Breton M.

Int J Family Med. 2017;2017:1595406. doi: 10.1155/2017/1595406. Epub 2017 Jul 10.

6.

Screening for Protein-Protein Interaction Inhibitors Using a Bioluminescence Resonance Energy Transfer (BRET)-Based Assay in Yeast.

Corbel C, Sartini S, Levati E, Colas P, Maillet L, Couturier C, Montanini B, Bach S.

SLAS Discov. 2017 Jul;22(6):751-759. doi: 10.1177/2472555216689530. Epub 2017 Jan 31.

PMID:
28346092
7.

Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL.

Le Pen J, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, Martinou JC, Letaï A, Braun F, Juin PP.

Cell Death Dis. 2017 Feb 9;8(2):e2596. doi: 10.1038/cddis.2016.127. No abstract available.

8.

Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.

Pécot J, Maillet L, Le Pen J, Vuillier C, Trécesson SC, Fétiveau A, Sarosiek KA, Bock FJ, Braun F, Letai A, Tait SWG, Gautier F, Juin PP.

Cell Rep. 2016 Dec 20;17(12):3347-3358. doi: 10.1016/j.celrep.2016.11.064.

9.

The performance of primary health care organizations depends on interdependences with the local environment.

Lamarche P, Maillet L.

J Health Organ Manag. 2016 Sep 19;30(6):836-54. doi: 10.1108/JHOM-09-2015-0150.

PMID:
27681020
10.

Perceptions of the first family physicians to adopt advanced access in the province of Quebec, Canada.

Breton M, Maillet L, Paré I, Abou Malham S, Touati N.

Int J Health Plann Manage. 2017 Oct;32(4):e316-e332. doi: 10.1002/hpm.2380. Epub 2016 Sep 8.

PMID:
27605412
11.

Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL.

Le Pen J, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, Martinou JC, Letaï A, Braun F, Juin PP.

Cell Death Dis. 2016 Feb 4;7:e2083. doi: 10.1038/cddis.2015.400. Erratum in: Cell Death Dis. 2017 Feb 9;8(2):e2596.

12.

TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.

Thébault S, Agez M, Chi X, Stojko J, Cura V, Telerman SB, Maillet L, Gautier F, Billas-Massobrio I, Birck C, Troffer-Charlier N, Karafin T, Honoré J, Senff-Ribeiro A, Montessuit S, Johnson CM, Juin P, Cianférani S, Martinou JC, Andrews DW, Amson R, Telerman A, Cavarelli J.

Sci Rep. 2016 Jan 27;6:19725. doi: 10.1038/srep19725.

13.

Bcl-xL controls a switch between cell death modes during mitotic arrest.

Bah N, Maillet L, Ryan J, Dubreil S, Gautier F, Letai A, Juin P, Barillé-Nion S.

Cell Death Dis. 2014 Jun 12;5:e1291. doi: 10.1038/cddis.2014.251. Erratum in: Cell Death Dis. 2014;5:e1429.

14.

[Neonatal outcome of fetal hyperechogenic bowel].

Maillet L, Rudigoz RC, Buffin R, Massardier J, Gaucherand P, Huissoud C.

Gynecol Obstet Fertil. 2014 Jun;42(6):383-6. doi: 10.1016/j.gyobfe.2014.01.006. Epub 2014 Feb 15. French.

PMID:
24533992
15.

[Spontaneous regression of breast cancer after biopsy. About two cases].

Maillet L, Chopin N, Treilleux I, Bachelot T, Tredan O, Faure C, Caux C, Beurrier F.

Gynecol Obstet Fertil. 2014 Apr;42(4):269-72. doi: 10.1016/j.gyobfe.2013.08.017. Epub 2014 Jan 3. French.

PMID:
24394327
16.
17.

Ploidy controls [URE3] prion propagation in yeast.

Crapeau M, Maillet L, Cullin C.

FEMS Yeast Res. 2014 Mar;14(2):324-36. doi: 10.1111/1567-1364.12110. Epub 2013 Nov 8.

18.

[Evaluation of endometrectomy by radiofrequency for premenopausal women: a retrospective study].

Maillet L, de Saint-Hilaire P, Rudigoz RC, Dubernard G.

J Gynecol Obstet Biol Reprod (Paris). 2013 Sep;42(5):458-63. doi: 10.1016/j.jgyn.2013.05.001. Epub 2013 Jun 21. French.

19.

pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.

Bertin-Ciftci J, Barré B, Le Pen J, Maillet L, Couriaud C, Juin P, Braun F.

Cell Death Differ. 2013 May;20(5):755-64. doi: 10.1038/cdd.2013.6. Epub 2013 Feb 22.

20.

The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion.

Crapeau M, Marchal C, Cullin C, Maillet L.

Mol Biol Cell. 2009 Apr;20(8):2286-96. doi: 10.1091/mbc.E08-11-1097. Epub 2009 Feb 18.

21.

In vitro analysis of SpUre2p, a prion-related protein, exemplifies the relationship between amyloid and prion.

Immel F, Jiang Y, Wang YQ, Marchal C, Maillet L, Perrett S, Cullin C.

J Biol Chem. 2007 Mar 16;282(11):7912-20. Epub 2007 Jan 17.

22.

The [URE3] prion is not conserved among Saccharomyces species.

Talarek N, Maillet L, Cullin C, Aigle M.

Genetics. 2005 Sep;171(1):23-34. Epub 2005 Jun 14.

23.

The Ccr4-Not complex independently controls both Msn2-dependent transcriptional activation--via a newly identified Glc7/Bud14 type I protein phosphatase module--and TFIID promoter distribution.

Lenssen E, James N, Pedruzzi I, Dubouloz F, Cameroni E, Bisig R, Maillet L, Werner M, Roosen J, Petrovic K, Winderickx J, Collart MA, De Virgilio C.

Mol Cell Biol. 2005 Jan;25(1):488-98.

24.

The [URE3] yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro.

Ripaud L, Maillet L, Immel-Torterotot F, Durand F, Cullin C.

J Biol Chem. 2004 Dec 3;279(49):50962-8. Epub 2004 Sep 28.

25.
26.

The Ccr4-not complex and yTAF1 (yTaf(II)130p/yTaf(II)145p) show physical and functional interactions.

Deluen C, James N, Maillet L, Molinete M, Theiler G, Lemaire M, Paquet N, Collart MA.

Mol Cell Biol. 2002 Oct;22(19):6735-49.

27.
28.

Ku-deficient yeast strains exhibit alternative states of silencing competence.

Maillet L, Gaden F, Brevet V, Fourel G, Martin SG, Dubrana K, Gasser SM, Gilson E.

EMBO Rep. 2001 Mar;2(3):203-10.

29.

The essential function of Not1 lies within the Ccr4-Not complex.

Maillet L, Tu C, Hong YK, Shuster EO, Collart MA.

J Mol Biol. 2000 Oct 20;303(2):131-43.

PMID:
11023781
30.

The clustering of telomeres and colocalization with Rap1, Sir3, and Sir4 proteins in wild-type Saccharomyces cerevisiae.

Gotta M, Laroche T, Formenton A, Maillet L, Scherthan H, Gasser SM.

J Cell Biol. 1996 Sep;134(6):1349-63.

31.
32.

Cooperation at a distance between silencers and proto-silencers at the yeast HML locus.

Boscheron C, Maillet L, Marcand S, Tsai-Pflugfelder M, Gasser SM, Gilson E.

EMBO J. 1996 May 1;15(9):2184-95.

33.
34.

Retroviral characteristics of the long terminal repeat of murine E.Tn sequences.

Kaghad M, Maillet L, Brûlet P.

EMBO J. 1985 Nov;4(11):2911-5.

Supplemental Content

Loading ...
Support Center